Naproxen Sodium

Product NDC: 70518-2863
11-digit product format: 705182863
Labeler code: 70518
Product ID: 70518-2863_dfe98d6e-f5d1-161b-e053-2995a90a1257
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Naproxen Sodium
Dosage form: TABLET
Route: ORAL
Labeler: REMEDYREPACK INC.
Application: ANDA212199
Marketing category: ANDA
Marketing start: 2020-08-27
Marketing end: 0000-00-00
Substance: NAPROXEN SODIUM
Active strength: 550 mg/1
Pharmacologic classes: Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	70518-2863		D	Discontinued by firm	2026-08-07
excluded package	package	70518-2863	70518-2863-0	D	Discontinued by firm	2026-08-07
excluded package	package	70518-2863	70518-2863-1	D	Discontinued by firm	2026-08-07

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 13 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	70518-2863-1	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	70518-2863-0	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	70518-2863-1	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	70518-2863-1	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	70518-2863-1	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	70518-2863-1	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	70518-2863-1	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	70518-2863-1	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	70518-2863-1	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	70518-2863-1	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	70518-2863-1	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	70518-2863-1	`367a005e9d99…`	`383a685ebd0f…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A212199-001	NAPROXEN SODIUM	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB		2019-10-30
A212199-002	NAPROXEN SODIUM	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB		2019-10-30

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A212199-001	AB
A212199-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 78 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A212199-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2019-10-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A212199-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2019-10-30	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A212199-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2019-10-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A212199-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2019-10-30	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A212199-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2019-10-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A212199-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2019-10-30	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A212199-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2019-10-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A212199-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2019-10-30	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A212199-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2019-10-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A212199-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2019-10-30	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A212199-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2019-10-30	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A212199-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2019-10-30	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A212199-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2019-10-30	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A212199-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2019-10-30	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A212199-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2019-10-30	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A212199-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2019-10-30	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A212199-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2019-10-30	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A212199-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2019-10-30	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A212199-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2019-10-30	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A212199-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2019-10-30	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A212199-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2019-10-30	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A212199-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2019-10-30	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A212199-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2019-10-30	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A212199-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2019-10-30	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A212199-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2019-10-30	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A212199-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2019-10-30	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A212199-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2019-10-30	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A212199-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2019-10-30	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A212199-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2019-10-30	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A212199-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2019-10-30	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A212199-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2019-10-30	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A212199-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2019-10-30	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A212199-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2019-10-30	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A212199-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2019-10-30	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A212199-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2019-10-30	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A212199-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2019-10-30	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A212199-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2019-10-30	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A212199-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2019-10-30	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A212199-001	NAPROXEN SODIUM	EQ 250MG BASE	TABLET / ORAL	AB	2019-10-30	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A212199-002	NAPROXEN SODIUM	EQ 500MG BASE	TABLET / ORAL	AB	2019-10-30	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 78 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A212199-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A212199-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A212199-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A212199-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A212199-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A212199-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A212199-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A212199-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A212199-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A212199-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A212199-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A212199-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A212199-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A212199-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A212199-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A212199-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A212199-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A212199-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A212199-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A212199-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A212199-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A212199-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A212199-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A212199-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A212199-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A212199-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A212199-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A212199-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A212199-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A212199-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A212199-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A212199-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A212199-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A212199-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A212199-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A212199-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A212199-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A212199-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A212199-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A212199-002	AB	1	`782e0a99824c…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
70518-2863-0	2022-02-07	C162847	48780-1	d6a99b39-7a48-a426-e053-dadaa90af4c2	These highlights do not include all the information needed to use NAPROXEN SODIUM TABLETS safely and effectively. See full prescribing information for NAPROXEN SODIUM TABLETS. NAPROXEN SODIUM tablets, for oral use Initial U.S. Approval: 1976
70518-2863-0	2022-01-28	C162847	48780-1	d6a99b39-7a48-a426-e053-dadaa90af4c2	These highlights do not include all the information needed to use NAPROXEN SODIUM TABLETS safely and effectively. See full prescribing information for NAPROXEN SODIUM TABLETS. NAPROXEN SODIUM tablets, for oral use Initial U.S. Approval: 1976

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
70518-2863	NAPROXEN SODIUM TABLET [REMEDYREPACK INC.]	9	Legacy NDC	20240921_3882db3d-acb9-4eb8-896f-55697a2a955c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 14 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Naproxen Sodium	NAPROXEN SODIUM	ScieGen Pharmaceuticals, Inc.	79f48c92-783d-40f2-9865-89958a9f9de6	2026-07-07	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212199 application number: ANDA212199
Naproxen Sodium	NAPROXEN SODIUM	ST. MARY'S MEDICAL PARK PHARMACY	181c2d5b-2c61-bf20-e063-6294a90a3f7f	2026-05-20	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212199 application number: ANDA212199
Naproxen Sodium	NAPROXEN SODIUM	Bryant Ranch Prepack	2794b60d-d09b-4115-9ff2-07ff15524e78	2026-05-15	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212199 application number: ANDA212199
Naproxen Sodium	NAPROXEN SODIUM	Bryant Ranch Prepack	bee7b482-8ba5-411d-90ee-de00df50d2b7	2026-04-14	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212199 application number: ANDA212199
Naproxen Sodium	NAPROXEN SODIUM	Bryant Ranch Prepack	e9eb8c40-85d9-4c8e-9523-a21d3591260f	2026-04-14	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212199 application number: ANDA212199
Naproxen Sodium	NAPROXEN SODIUM	Bryant Ranch Prepack	f6f4a670-235e-4235-84a8-a74dc8ca5586	2026-04-13	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212199 application number: ANDA212199
Naproxen Sodium	NAPROXEN SODIUM	Advanced Rx of Tennessee, LLC	369911ea-9069-9c45-e063-6394a90a5ce6	2026-02-12	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212199 application number: ANDA212199
Naproxen Sodium	NAPROXEN SODIUM	Advanced Rx of Tennessee, LLC	4a05ca8c-1b03-fa86-e063-6394a90a4119	2026-02-04	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212199 application number: ANDA212199
Naproxen Sodium	NAPROXEN SODIUM	PD-Rx Pharmaceuticals, Inc.	145cdcc0-9bd5-4a0e-81fc-11a24d181980	2026-01-05	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212199 application number: ANDA212199
Naproxen Sodium	NAPROXEN SODIUM	Preferred Pharmaceuticals, Inc.	6ae413ba-5a48-423f-8b8d-7a42661cf836	2025-08-18	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212199 application number: ANDA212199
Naproxen Sodium	NAPROXEN SODIUM	Direct Rx	d95279d9-6e2a-0bd6-e053-2a95a90a447d	2025-01-21		Exact identifier application applno (ANDA): 212199 application number: ANDA212199
Naproxen Sodium	NAPROXEN SODIUM	NuCare Pharmaceuticals,Inc.	b8e417d2-3fc8-9a5e-e053-2a95a90a4155	2025-01-03	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212199 application number: ANDA212199
Naproxen Sodium	NAPROXEN SODIUM	Asclemed USA, Inc.	b0571e62-9330-438d-a2ba-873477f52dc4	2023-10-18	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212199 application number: ANDA212199
Naproxen Sodium	NAPROXEN SODIUM	Proficient Rx LP	a90bfc07-d01e-427c-b2df-41bff7612d2f	2022-07-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 212199 application number: ANDA212199

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
9TN87S3A3C	NAPROXEN SODIUM	26159-34-2	NAPROXEN SODIUM

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
70518-2863-0	70518286300	30 TABLET in 1 BOTTLE, PLASTIC (70518-2863-0)	30 tablet	2020-08-27	0000-00-00	No	No	Current
70518-2863-1	70518286301	30 TABLET in 1 BOTTLE, PLASTIC (70518-2863-1)	30 tablet	2022-05-24	0000-00-00	No	No	Current